author-photo

Lujing Zhan

Eli Lilly and Company

2

Papers

4

Citations

Citation Trend

Filter By

Papers (2) Sort By

Journal Conference Others

Patient-reported outcomes from a randomized, double-blind, placebo controlled, phase III study of baricitinib versus placebo in patients with moderately to severely active rheumatoid arthritis and an inadequate response to methotrexate therapy: results from the RA-BALANCE study

2021 Therapeutic Advances in Musculoskeletal Disease
Show All
- Source
- Cite
- Save
Citations (0)
Baricitinib in patients with rheumatoid arthritis with inadequate response to methotrexate: results from a phase 3 study.

2020 Clinical and Experimental Rheumatology
Show All
- Source
- Cite
- Save
Citations (4)